These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 26389729

  • 1. Significance of miR-148a in Colorectal Neoplasia: Downregulation of miR-148a Contributes to the Carcinogenesis and Cell Invasion of Colorectal Cancer.
    Hibino Y, Sakamoto N, Naito Y, Goto K, Oo HZ, Sentani K, Hinoi T, Ohdan H, Oue N, Yasui W.
    Pathobiology; 2015; 82(5):233-41. PubMed ID: 26389729
    [Abstract] [Full Text] [Related]

  • 2. MicroRNA-148a is downregulated in gastric cancer, targets MMP7, and indicates tumor invasiveness and poor prognosis.
    Sakamoto N, Naito Y, Oue N, Sentani K, Uraoka N, Oo HZ, Yanagihara K, Aoyagi K, Sasaki H, Yasui W.
    Cancer Sci; 2014 Feb; 105(2):236-43. PubMed ID: 24283384
    [Abstract] [Full Text] [Related]

  • 3. Genetic and epigenetic down-regulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD.
    Meng X, Wu J, Pan C, Wang H, Ying X, Zhou Y, Yu H, Zuo Y, Pan Z, Liu RY, Huang W.
    Gastroenterology; 2013 Aug; 145(2):426-36.e1-6. PubMed ID: 23583431
    [Abstract] [Full Text] [Related]

  • 4. MicroRNA-143 inhibits colorectal cancer cell proliferation by targeting MMP7.
    Yu B, Liu X, Chang H.
    Minerva Med; 2017 Feb; 108(1):13-19. PubMed ID: 27827523
    [Abstract] [Full Text] [Related]

  • 5. miRNA-503 Promotes Tumor Progression and Is Associated with Early Recurrence and Poor Prognosis in Human Colorectal Cancer.
    Noguchi T, Toiyama Y, Kitajima T, Imaoka H, Hiro J, Saigusa S, Tanaka K, Inoue Y, Mohri Y, Toden S, Kusunoki M.
    Oncology; 2016 Feb; 90(4):221-31. PubMed ID: 26999740
    [Abstract] [Full Text] [Related]

  • 6. Clinical and biological significance of miR-378a-3p and miR-378a-5p in colorectal cancer.
    Li H, Dai S, Zhen T, Shi H, Zhang F, Yang Y, Kang L, Liang Y, Han A.
    Eur J Cancer; 2014 Apr; 50(6):1207-21. PubMed ID: 24412052
    [Abstract] [Full Text] [Related]

  • 7. Down-regulation of miR-24-3p in colorectal cancer is associated with malignant behavior.
    Gao Y, Liu Y, Du L, Li J, Qu A, Zhang X, Wang L, Wang C.
    Med Oncol; 2015 Jan; 32(1):362. PubMed ID: 25502080
    [Abstract] [Full Text] [Related]

  • 8. miR-150 as a potential biomarker associated with prognosis and therapeutic outcome in colorectal cancer.
    Ma Y, Zhang P, Wang F, Zhang H, Yang J, Peng J, Liu W, Qin H.
    Gut; 2012 Oct; 61(10):1447-53. PubMed ID: 22052060
    [Abstract] [Full Text] [Related]

  • 9. Identification of microRNA-214 as a negative regulator of colorectal cancer liver metastasis by way of regulation of fibroblast growth factor receptor 1 expression.
    Chen DL, Wang ZQ, Zeng ZL, Wu WJ, Zhang DS, Luo HY, Wang F, Qiu MZ, Wang DS, Ren C, Wang FH, Chiao LJ, Pelicano H, Huang P, Li YH, Xu RH.
    Hepatology; 2014 Aug; 60(2):598-609. PubMed ID: 24616020
    [Abstract] [Full Text] [Related]

  • 10. Downregulation of rho-associated protein kinase 1 by miR-124 in colorectal cancer.
    Xi ZW, Xin SY, Zhou LQ, Yuan HX, Wang Q, Chen KX.
    World J Gastroenterol; 2015 May 14; 21(18):5454-64. PubMed ID: 25987767
    [Abstract] [Full Text] [Related]

  • 11. The clinical significance of MiR-148a as a predictive biomarker in patients with advanced colorectal cancer.
    Takahashi M, Cuatrecasas M, Balaguer F, Hur K, Toiyama Y, Castells A, Boland CR, Goel A.
    PLoS One; 2012 May 14; 7(10):e46684. PubMed ID: 23056401
    [Abstract] [Full Text] [Related]

  • 12. Up-regulated miR-155-5p promotes cell proliferation, invasion and metastasis in colorectal carcinoma.
    Qu YL, Wang HF, Sun ZQ, Tang Y, Han XN, Yu XB, Liu K.
    Int J Clin Exp Pathol; 2015 May 14; 8(6):6988-94. PubMed ID: 26261588
    [Abstract] [Full Text] [Related]

  • 13. miR-182 promotes cell growth and invasion by targeting forkhead box F2 transcription factor in colorectal cancer.
    Zhang Y, Wang X, Wang Z, Tang H, Fan H, Guo Q.
    Oncol Rep; 2015 May 14; 33(5):2592-8. PubMed ID: 25738520
    [Abstract] [Full Text] [Related]

  • 14. MiR-148a suppressed cell invasion and migration via targeting WNT10b and modulating β-catenin signaling in cisplatin-resistant colorectal cancer cells.
    Shi L, Xi J, Xu X, Peng B, Zhang B.
    Biomed Pharmacother; 2019 Jan 14; 109():902-909. PubMed ID: 30551544
    [Abstract] [Full Text] [Related]

  • 15. MicroRNA-223 functions as an oncogene in human colorectal cancer cells.
    Zhang J, Luo X, Li H, Yue X, Deng L, Cui Y, Lu Y.
    Oncol Rep; 2014 Jul 14; 32(1):115-20. PubMed ID: 24819398
    [Abstract] [Full Text] [Related]

  • 16. Downregulation of miR-199b is associated with distant metastasis in colorectal cancer via activation of SIRT1 and inhibition of CREB/KISS1 signaling.
    Shen ZL, Wang B, Jiang KW, Ye CX, Cheng C, Yan YC, Zhang JZ, Yang Y, Gao ZD, Ye YJ, Wang S.
    Oncotarget; 2016 Jun 07; 7(23):35092-105. PubMed ID: 27145368
    [Abstract] [Full Text] [Related]

  • 17. MicroRNA-9 suppresses cell migration and invasion through downregulation of TM4SF1 in colorectal cancer.
    Park YR, Lee ST, Kim SL, Liu YC, Lee MR, Shin JH, Seo SY, Kim SH, Kim IH, Lee SO, Kim SW.
    Int J Oncol; 2016 May 07; 48(5):2135-43. PubMed ID: 26983891
    [Abstract] [Full Text] [Related]

  • 18. Decreased Expression of MIR-134 and its Clinical Significance in Human Colorectal Cancer.
    Xie Y, Song J, Zong Q, Wang A, Yang Y, Liu F, Meng X.
    Hepatogastroenterology; 2015 May 07; 62(139):615-9. PubMed ID: 26897940
    [Abstract] [Full Text] [Related]

  • 19. Altered miR-21, miRNA-148a Expression in Relation to KRAS Mutation Status as Indicator of Adenoma-Carcinoma Transitional Pattern in Colorectal Adenoma and Carcinoma Lesions.
    Igder S, Mohammadiasl J, Mokarram P.
    Biochem Genet; 2019 Dec 07; 57(6):767-780. PubMed ID: 30997628
    [Abstract] [Full Text] [Related]

  • 20. Clinical significance of microRNA-21 as a biomarker in each Dukes' stage of colorectal cancer.
    Fukushima Y, Iinuma H, Tsukamoto M, Matsuda K, Hashiguchi Y.
    Oncol Rep; 2015 Feb 07; 33(2):573-82. PubMed ID: 25421755
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.